Time to SGLT2 inhibitors initiation in patients with heart failure
Moon J, Udell JA, Chong A, Fang J, Austin PC, Ko DT, Stukel TA, Atzema CL, Booth GL, Tu K, Naimark DMJ, Jackevicius CA. J Am Heart Assoc. 2024; Apr 2 [Epub ahead of print].
Publications
Population trends of new prescriptions for antihyperglycemics and antihypertensives between 2014 and 2022
Yu AYX, Austin PC, Jackevicius CA, Chu A, Holodinsky JK, Hill MD, Kamal N, Kumar M, Lee DS, Vyas MV, Joundi RA, Khan NA, Kapral MK, McNaughton CD. J Am Heart Assoc. 2024; Apr 2 [Epub ahead of print].
Association of neighborhood-level marginalization with healthcare use and clinical outcomes following hospital discharge in patients who underwent coronary catheterization for acute myocardial infarction in a single-payer healthcare system
Akioyamen LE, Abdel-Qadir H, Han L, Sud M, Mistry N, Alter DA, Atzema CL, Austin PC, Bhatia RS, Booth GL, Dhalla I, Ha ACT, Jackevicius CA, Kapral MK, Krumholz HM, Lee DS, McNaughton CD, Roifman I, Schull MJ, Sivaswamy A, Tu K, Udell JA, Wijeysundera HC, Ko DT. Circ Cardiovasc Qual Outcomes. 2023; Dec 5 [Epub ahead of print].
Association of neighborhood-level material deprivation with adverse outcomes and processes of care among patients with heart failure in a single-payer healthcare system: a population-based cohort study
Bobrowski D, Dorovenis A, Abdel-Qadir H, McNaughton CD, Alonzo R, Fang J, Austin PC, Udell JA, Jackevicius CA, Alter DA, Atzema CL, Bhatia RS, Booth GL, Ha ACT, Johnston S, Dhalla I, Kapral MK, Krumholz HM, Roifman I, Wijeysundera HC, Ko DT, Tu K, Ross HJ, Schull MJ, Lee DS. Eur J Heart Fail. 2023; Nov 13 [Epub ahead of print].
Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes
Moon J, Ozaki AF, Chong A, Sud M, Fang J, Austin PC, Ko DT, Jackevicius CA. Pharmacoepidemiol Drug Saf. 2023; Sep 29 [Epub ahead of print].
Statin use and stroke rate in older adults with atrial fibrillation: a population-based cohort study
Shweikialrefaee B, Ko DT, Fang J, Pang A, Austin PC, Dorian P, Singh SM, Jackevicius CA, Tu K, Lee DS, Abdel-Qadir H.
Prescribing patterns and factors associated with sodium-glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease
Ozaki AF, Ko DT, Chong A, Fang J, Atzema CL, Austin PC, Stukel TA, Tu K, Udell JA, Naimark D, Booth GL, Jackevicius CA. CMAJ Open. 2023; 11(3):E494-503. Epub 2023 Jun 13.
Association of beta-blocker therapy with cardiovascular outcomes in patients with stable ischemic heart disease
Godoy LC, Farkouh ME, Austin PC, Shah BR, Qiu F, Jackevicius CA, Wijeysundera HC, Krumholz HM, Ko DT. J Am Coll Cardiol. 2023; 81(24):2299-311. Epub 2023 Jun 12.
Sex-based differences in severe outcomes, including cardiovascular hospitalization, in adults with COVID-19 in Ontario, Canada
Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Abdel-Qadir H, Atzema CL, Jackevicius C, Kapral MK, Wijeysundera HC, Farkouh ME, Ross HJ, Ha ACT, Tadrous M, Paterson M, Gershon AS, Dzavík V, Fang J, Kaul P, van Diepen S, Goodman SG, Ezekowitz JA, Bainey KR, Ko DT, Austin PC, McAlister FA, Lee DS, Udell JA. JACC Adv. 2023; May 10 [Epub ahead of print].
Association of race and ethnicity with obstructive coronary artery disease
Rooprai J, Qiu F, PorterJ, Abdel-Qadir H, Godoy LC, Jackevicius CA, Lee DS, Madan M, Shah BR, Sud M, Wijeysundera HC, Ko DT. JACC Adv. 2023; 2(1):100161. Epub 2023 Jan 11.